Tenaya Therapeutics, Inc. (NASDAQ:TNYA), a biotechnology company with a mission to discover, develop and deliver curative therapies that address the underlying causes of heart disease, today announced participation at several upcoming investor conferences.

Details of each presentation are as follows:

Cowen 2^nd Annual Genetic Medicines Summit

Panel: Gene Therapies - Clinical Topics

Date: Thursday, February 3, 2022

Time: 12:00 p.m. ET

SVB Leerink Global Healthcare Conference

Company Presentation

Date: Friday, February 18, 2022

Time: 3:40 p.m. ET

Cowen 42^nd Annual Health Care Conference

Panel: Gene Therapy

Date: Wednesday March 9, 2022

Time: 12:50 p.m. ET

About Tenaya Therapeutics

Tenaya Therapeutics is a biotechnology company committed to a bold mission: to discover, develop and deliver curative therapies that address the underlying drivers of heart disease. Founded by leading cardiovascular scientists from Gladstone Institutes and the University of Texas Southwestern Medical Center, Tenaya is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. For more information, visit www.tenayatherapeutics.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220131005192/en/